TCG Crossover GP II, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Nektar Therapeutics Common Stock, par value $0.0001 per share (NKTR)

Filing Manager
TCG Crossover GP II, LLC
Reporting Manager
TCG Crossover GP II, LLC
Security
Nektar Therapeutics Common Stock, par value $0.0001 per share
Symbol
NKTR
Shares outstanding
20.8M shares
Disclosed Ownership
1.93M shares
Ownership
9.3%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:14:00 UTC
Date of event
30 Jun 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TCG Crossover GP II, LLC 9.3% 1.93M 0 1.93M /s/ Craig Skaling Craig Skaling, Authorized Signatory
TCG Crossover Fund II, L.P. 9.3% 1.93M 0 1.93M /s/ Craig Skaling Craig Skaling, Authorized Signatory
Chen Yu 9.3% 1.93M 0 1.93M /s/ Craig Skaling Craig Skaling, as Attorney-in-Fact for Chen Yu